GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins September 04, 2024
Displaying entries 4801 - 4850 of 39437 in total
PDB ID UniProt ID Title Descriptor ▼
6MET P51681 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
6MET Q70145 Structural basis of coreceptor recognition by HIV-1 envelope spike Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, C-C chemokine receptor type 5
6CM3 Q2N0S7 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CM3 Q2N0S5 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CM3 P01730 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6CM3 6CM3 BG505 SOSIP in complex with sCD4, 17b, 8ANC195 Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain
6EDU B3UEZ6 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6EDU B3UES2 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6EDU P01730 B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6EDU 6EDU B41 SOSIP.664 in complex with soluble CD4 (D1-D2), the co-receptor mimicking antibody 21c and the broadly neutralizing antibody 8ANC195 Envelope glycoprotein gp160, PG9 Fab heavy chain,PG9 Fab heavy chain, PG9 Fab light chain,PG9 Fab light chain, 8ANC195 Fab heavy chain,8ANC195 Fab heavy chain, 8ANC195 Fab light chain,8ANC195 Fab light chain
6DID Q2N0S6 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID Q2N0S7 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID 6DID HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID P01840 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID 6DID HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID P01840 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID A0A1Y1B8B1 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6DID A0A1Y1B8B1 HIV Env BG505 SOSIP with polyclonal Fabs from immunized rabbit #3417 post-boost#1 Envelope glycoprotein gp160, Monoclonal antibody 10A light chain, Monoclonal antibody 10A heavy chain
6SNE 6SNE crystal structure of LN01 Fab in complex with an HIV-1 gp41 peptide Envelope glycoprotein gp160, LN01 light chain, LN01 heavy chain
6SNE Q74599 crystal structure of LN01 Fab in complex with an HIV-1 gp41 peptide Envelope glycoprotein gp160, LN01 light chain, LN01 heavy chain
6DCQ A0A2H4K974 Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ S6B291 Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ 6DCQ Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ S6B291 Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ 6DCQ Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ Q8TCD0 Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6DCQ Q8TCD0 Ectodomain of full length, wild type HIV-1 glycoprotein clone PC64M18C043 in complex with PGT151 Fab Envelope glycoprotein gp160, Immunoglobulin G PGT151 Fab, Heavy chain, Immunoglobulin G PGT151 Fab, Light chain
6OPN B3UES2 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
6OPN B3UEZ6 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
6OPN P01730 CD4- and 17-bound HIV-1 Env B41 SOSIP in complex with small molecule GO35 Envelope glycoprotein gp160, Envelope glycoprotein gp41, T-cell surface glycoprotein CD4
6OZC Q2N0S6 BG505 SOSIP.664 with 2G12 Fab2 Envelope glycoprotein gp160, Envelope glycoprotein gp41, 2G12 Fab light chain, 2G12 Fab Heavy chain
6OZC 6OZC BG505 SOSIP.664 with 2G12 Fab2 Envelope glycoprotein gp160, Envelope glycoprotein gp41, 2G12 Fab light chain, 2G12 Fab Heavy chain
6VKN Q2N0S6 BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain
6VKN 6VKN BG505 SOSIP.v5.2.N241.N289 in complex with rhesus macaque Fab RM19R Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain
6VN0 Q2N0S6 BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain
6VN0 6VN0 BG505 SOSIP.v4.1 in complex with rhesus macaque Fab RM20F Envelope glycoprotein gp160, BG505 SOSIPv5.2 gp41, RM19R Kappa Light Chain, RM19R Heavy Chain
5VIY Q2N0S6 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY P01834 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY P01834 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY 5VIY BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY S6B291 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY S6B291 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY Q8TCD0 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
5VIY Q8TCD0 BG505 SOSIP.664 in complex with broadly neutralizing antibodies BG1 and 8ANC195 Envelope glycoprotein gp160, BG1 Fab light chain,BG1 Fab light chain, BG1 Fab heavy chain,BG1 Fab heavy chain, 8ANC195 G52K5 Fab heavy chain,8ANC195 G52K5 Fab heavy chain, 8ANC195 G52K5 Fab light chain,8ANC195 G52K5 Fab light chain
6MU6 Q2N0S6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MU6 6MU6 Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry Inhibitor BMS-814508 in Complex with Human Antibodies 3H109L and 35O22 at 3.2 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MUF B3UEZ6 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MUF 6MUF Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain
6MUF B3UES2 Crystal Structure of HIV-1 B41 SOSIP.664 Prefusion Env Trimer in Complex with Human Antibodies 3H109L and 35O22 at 3.4 Angstrom Envelope glycoprotein gp160, 35O22 scFv heavy chain portion, 35O22 scFv light chain portion, 3H109L Fab heavy chain, 3H109L Fab light chain

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024